Advances in Genetics and Genomics: From Mechanisms to Medicine

Abstract

Introduction: Advances in genetics and genomics have transformed biomedical sciences, offering deeper insights into disease mechanisms and enabling precision medicine. Genomic technologies such as next-generation sequencing (NGS), genome-wide association studies (GWAS), and CRISPR-based editing have provided unprecedented opportunities to translate research findings into clinical care. The completion of the Human Genome Project and subsequent developments in sequencing technologies have enabled precision medicine approaches.

Materials and Methods: This was a prospective, multicenter observational study conducted from January 2024 to June 2025 across four tertiary-care institutions. The study aimed to evaluate the impact of genetic and genomic technologies on diagnosis, prognosis, and treatment outcomes. Whole-exome sequencing, GWAS, and transcriptomic profiling were employed. Inclusion criteria encompassed patients aged 18–70 with confirmed or suspected genetic conditions; exclusion criteria included poor survival prognosis (<6 months) and inability to consent.

Results: Genomic technologies revealed pathogenic variants in 40% of cases, while GWAS identified novel associations in 15%. CRISPR-based preclinical interventions demonstrated promising disease correction in 12% of experimental models. Six tables summarize demographic data, variant yield, disease distribution, pharmacogenomic applications, cost-effectiveness, and comparison with previous landmark studies.

Conclusion: Genetics and genomics are redefining the understanding of human disease, advancing translational medicine from mechanism discovery to clinical application. However, challenges remain in equitable access, data interpretation, and ethical governance.